Back to Search
SUZANNE MICHELS, PH.D.
PH.D.
Clinical Psychologist
NPI: 1194899989Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
0810002004(VA)
Research & Publications (20)
Bovine thrombin safety reporting: an example of study design and publication bias.
PMID 19589547·J Surg Res·2010
6-review
Effect of intravitreal bevacizumab (Avastin) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results.
PMID 19485959·Acta Ophthalmol·2010
8-other
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results.
PMID 19169239·Eye (Lond)·2009
4-observational
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
PMID 19376495·Am J Ophthalmol·2009
3-trial
Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration.
PMID 18756282·Eye (Lond)·2009
8-other
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.
PMID 19074916·Br J Ophthalmol·2009
3-trial
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
PMID 18303156·Br J Ophthalmol·2008
2-rct
[Intravitreal anti-VEGF therapy for capillary hemangioblastomas in von Hippel-Lindau disease].
PMID 18401796·Klin Monbl Augenheilkd·2008
5-case
Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy.
PMID 18463510·Retina·2008
8-other
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study.
PMID 18586901·Br J Ophthalmol·2008
4-observational
Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography.
PMID 18852747·Opt Express·2008
8-other
Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study.
PMID 19029163·Br J Ophthalmol·2008
8-other
Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium.
PMID 18227201·Br J Ophthalmol·2008
8-other
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.
PMID 18211942·Br J Ophthalmol·2008
3-trial
Exogenous bovine thrombin as a biomarker of exposure and outcome.
PMID 18785812·Expert Rev Mol Diagn·2008
6-review
Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
PMID 17408387·Acta Ophthalmol Scand·2007
5-case
Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).
PMID 17433023·Acta Ophthalmol Scand·2007
5-case
[Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration].
PMID 17564719·Ophthalmologe·2007
2-rct
Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.
PMID 17916314·Am J Ophthalmol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 934 E JEFFERSON ST
CHARLOTTESVILLE, VA 22902 - Phone
- (434) 296-0762
Quick Facts
- NPI
- 1194899989
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile